Company news
Novonesis A/s Class B (OMXCOP:NSIS_B) news
Every Novonesis A/s Class B press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Interim report Q1 2026
May 5, 2026
Resolutions from the Annual General Meeting 2026
March 23, 2026
Novonesis issues EUR 1.7 billion in bonds to refinance bridge facility
March 16, 2026
Novonesis issues EUR 1.7 billion senior unsecured notes
March 13, 2026
Invitation to the 2026 Annual General Meeting
February 26, 2026
Novonesis delivered strong organic sales growth of 7% in 2025
February 25, 2026
Novonesis delivered 8% organic sales growth in the first nine months of 2025
November 6, 2025
8% organic sales growth after first nine months. Full-year organic sales growth narrowed upwards.
November 6, 2025
Noma and Novonesis partner to scale deliciousness
October 23, 2025
Novo Holdings to make changes to its Board of Directors
October 21, 2025
Novonesis and Novo Nordisk will explore new solutions to improve metabolic health
September 8, 2025
Novonesis delivered 9% organic sales growth in H1 and full-year outlook range narrowed to 6-8%
August 21, 2025
Interim report H1 2025
August 21, 2025
2030 financial targets announced: Organic sales growth acceleration, margin expansion and ROIC improvement
August 20, 2025
Combining EVP roles of Human Health Biosolutions and Strategy & Integration
May 19, 2025
Novonesis delivered a strong Q1 with 11% organic growth and confirms full-year outlook
May 8, 2025
Interim report Q1 2025
May 8, 2025